glp 1 agonist statpearls Frontiers GLP-1 Receptor Agonist Market Growth
Description
Ed.) 2012;344:e1369

Low-cost options are available

Are triglycerides, cholesterol, and blood pressure improving

In everyday clinical practice, a combination of different strategies, for example, diet with metformin and statins, is very common, considering that it is the treatment indicated for the conditions which are causally linked to the pathogenesis of NAFLD/NASH

2,3 In addition to these mechanisms, GLP-1 RAs also delay gastric emptying, thereby contributing to enhanced postprandial glucose regulation and increased satiety, ultimately supporting reduced caloric intake and weight management

PREDIMED and long-term weight outcomes
